nForm Blog
Category: Oncology
GeoMx Oncology
Breast Cancer: Best practices for using GeoMx® Digital Spatial Profiler
It’s October and breast cancer awareness month. Breast cancer kills more women than any other type of cancer. It isn’t just limited to women either – a man’s lifetime breast…
Oncology Q&A
What is the Next Frontier in Cellular Therapy?
In early June 2021, NanoString and the Parker Institute for Cancer Immunotherapy (PICI) announced a multi-center collaboration to characterize 800 CAR-T samples in a unique and concerted effort to understand…
Oncology Panels Q&A
A “Tail” of Two Species: New Canine Immuno-Oncology Research Offering.
NanoString has an unparalleled and longstanding tradition of developing best in class cancer research tools, thanks to an extensive knowledge accumulated in a decade of interrogating all aspects of the…
Infectious Disease Oncology
Of Mice and Men: The importance of Mouse Models in Research.
Many animals share common biology with humans, are affected by similar diseases, and may have a comparable response to certain treatments. Animal models are thus useful to address scientific questions…
Oncology
NanoString Proudly Introduces the new nCounter® Canine IO Panel.
It may have happened to you, as it happened to some of us here at NanoString®: the furry, four-legged trouble-making family member you just can’t stay mad at is sick,…
Events Oncology
SITC in Focus: CAR-T Cell Therapy
The Society for Immunotherapy of Cancer (SITC) held its annual meeting online this year. Notable were the presentations in New Approaches for CAR-T Cell Therapies: Technology Symposium Featuring GeoMx® Digital…
Oncology
From an Egyptian Papyrus to the Hallmarks of Cancer: A Journey through the Development of Knowledge in Oncology Research
The word “cancer” was used for the first time in ancient Greece by Hippocrates, often termed the Father of Medicine for his contributions to modern medical practice. Even prior to…
Oncology Panels Q&A
Statistically Significant Results without the Headache. Q&A with Sarah Church, PhD, Senior Scientist at NanoString.
Talking to Sarah, whether during social gatherings or within the office walls, is always a pleasure. Dr. Church is a Senior Scientist at NanoString, and one of the warmest people…
Oncology Q&A
Going Beyond PDL-1. Q&A with Dr. Nina Radosevic- Robin, MD.
Dr. Nina Radosevic-Robin, MD, is a Board-Certified Surgical/Molecular Pathologist at Centre Jean Perrin, a Sr. Scientist within the Unit 1240 of French National Institute for Medical Research (INSERM), and a…
Immunology Oncology Q&A
Why is Digital Spatial Profiling Critical to Studying Sarcomas? Q&A with Dr. Troy McEachron, Ph.D
“Whereas the EWS specimens tended to have very simple genomes, the osteosarcoma specimens looked like a hand grenade had gone off in the genome. These were the most fragmented and…
Autoimmunity Digital Spatial Profiling Neuroscience Oncology
Readers’ Favorite Webinars: A Year in Review
NanoString webinars allow you to sit back, relax and listen to a leader in the field talk about his/her research and/or answer your questions. They have always been a crowd-pleaser,…
Autoimmunity Oncology
Top 5 Q&A Blog Posts from 2019
Our readers heartily consumed our Q&A blog posts, a series of interviews with scientists from all over the globe who shared with us and our readers the hypotheses behind their…